Search research articles
Contact Us
Filters
Showing results (91-100 of 181) with videos related to
Page
of 19
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
December 21, 2013
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis
James Foran, Farhad Ravandi, William Wierda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin
Farhad Ravandi, Eli Estey, Dan Jones, et al.
Blood
|
August 16, 2008
Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia
Deborah A Thomas, Susan O'Brien, Jeffrey L Jorgensen, et al.
Cancer
|
December 15, 2005
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens
William Wierda, Susan O'brien, Stefan Faderl, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
Michael J Keating, Susan O'Brien, Maher Albitar, et al.
Molecular Cancer Research : MCR
|
May 20, 2014
STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis
Ping Li, David Harris, Zhiming Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms
Farhad Ravandi, Ahmed Aribi, Susan O'Brien, et al.
American Journal of Hematology
|
April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemia
Farshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex
Uri Rozovski, David M Harris, Ping Li, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 181) with videos related to
Sort By:
Page
of 19
Clinical Lymphoma, Myeloma & Leukemia
|
December 21, 2013
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis
James Foran, Farhad Ravandi, William Wierda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2008
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin
Farhad Ravandi, Eli Estey, Dan Jones, et al.
Blood
|
August 16, 2008
Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia
Deborah A Thomas, Susan O'Brien, Jeffrey L Jorgensen, et al.
Cancer
|
December 15, 2005
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens
William Wierda, Susan O'brien, Stefan Faderl, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
Michael J Keating, Susan O'Brien, Maher Albitar, et al.
Molecular Cancer Research : MCR
|
May 20, 2014
STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis
Ping Li, David Harris, Zhiming Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms
Farhad Ravandi, Ahmed Aribi, Susan O'Brien, et al.
American Journal of Hematology
|
April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemia
Farshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex
Uri Rozovski, David M Harris, Ping Li, et al.
Page
of 19